ArticleNature communications2024

Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer.

Sakina A Plumber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.